BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35434378)

  • 1. Human amniotic fluid as a source of stem cells.
    Walentowicz P; Sadlecki P; Walentowicz-Sadlecka M; Bajek A; Grabiec M; Drewa T
    Open Med (Wars); 2022; 17(1):648-660. PubMed ID: 35434378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz].
    Sadłecki P; Walentowicz-Sadłecka M; Pasińska M; Adamczak R; Grabiec M
    Ginekol Pol; 2014 Jun; 85(6):420-3. PubMed ID: 25029805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion.
    Abe Y; Ochiai D; Masuda H; Sato Y; Otani T; Fukutake M; Ikenoue S; Miyakoshi K; Okano H; Tanaka M
    Stem Cells Transl Med; 2019 Nov; 8(11):1170-1179. PubMed ID: 31407874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential use of stem cells derived from human amniotic fluid in renal diseases.
    Noronha IL; Cavaglieri RC; Janz FL; Duarte SA; Lopes MA; Zugaib M; Bydlowski SP
    Kidney Int Suppl (2011); 2011 Sep; 1(3):77-82. PubMed ID: 25028628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
    Tarim E; Bağiş T; Kiliçdağ EB; Sezgin N; Yanik F
    J Perinat Med; 2005; 33(6):524-9. PubMed ID: 16318616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel method for amniotic fluid stem cell storage.
    Zavatti M; Beretti F; Casciaro F; Comitini G; Franchi F; Barbieri V; Bertoni L; De Pol A; La Sala GB; Maraldi T
    Cytotherapy; 2017 Aug; 19(8):1002-1012. PubMed ID: 28571656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maternal-fetal movement on concentration of cells obtained at genetic amniocentesis.
    Carlan SJ; Papenhausen P; O'Brien WF; Pietrantoni M; Chez RA; Stephens P
    Am J Obstet Gynecol; 1990 Aug; 163(2):490-3. PubMed ID: 2386135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and fetal growth in human pregnancy.
    La Marca-Ghaemmaghami P; Dainese SM; Stalla G; Haller M; Zimmermann R; Ehlert U
    Stress; 2017 May; 20(3):231-240. PubMed ID: 28347187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS.
    Shaw SWS; Cheng PJ; Chang YL; Chao AS; Wang TH; Chang SD; Hsieh TT; Chang KH
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):770-774. PubMed ID: 29241918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages.
    Sato Y; Ochiai D; Abe Y; Masuda H; Fukutake M; Ikenoue S; Kasuga Y; Shimoda M; Kanai Y; Tanaka M
    Stem Cell Res Ther; 2020 Jul; 11(1):300. PubMed ID: 32690106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human amniotic fluid stem cells (hAFSCs) expressing p21 and cyclin D1 genes retain excellent viability after freezing with (dimethyl sulfoxide) DMSO.
    Gholizadeh-Ghaleh Aziz S; Fardyazar Z; Pashaei-Asl F; Rahmati-Yamchi M; Khodadadi K; Pashaiasl M
    Bosn J Basic Med Sci; 2019 Feb; 19(1):43-51. PubMed ID: 29688163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Residue amniotic fluid volume after preterm premature rupture of membranes and maternal-fetal outcome.].
    Huang S; Qi HB; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):726-30. PubMed ID: 20078956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the maternal position and rest on the fetal urine production rate: a prospective study conducted by 3-dimensional sonography using the rotational technique (virtual organ computer-aided analysis).
    Ülker K; Çeçen K; Temur İ; Gül A; Karaca M
    J Ultrasound Med; 2011 Apr; 30(4):481-6. PubMed ID: 21460147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery.
    Ghezzi F; Franchi M; Raio L; Di Naro E; Bossi G; D'Eril GV; Bolis P
    Am J Obstet Gynecol; 2002 Feb; 186(2):268-73. PubMed ID: 11854648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filtration and recirculation of early amniotic fluid. Evaluation of cell cultures from 100 diagnostic cases.
    Sundberg K; Smidt-Jensen S; Lundsteen C; Agerbaek K; Philip J
    Prenat Diagn; 1993 Dec; 13(12):1101-10. PubMed ID: 8177830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of different culture conditions on isolation and expansion of stem cells from second-trimester amniotic fluids].
    Liu H; Liu DQ; Guan LD; Yan ZF; Wang J; He LJ; Lü Y; Nan X; Li YL; Pei XT
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):241-5. PubMed ID: 19570457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial invasion and preterm delivery.
    Daskalakis G; Thomakos N; Papapanagiotou A; Papantoniou N; Mesogitis S; Antsaklis A
    BJOG; 2009 Dec; 116(13):1743-8. PubMed ID: 19906019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
    Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
    Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
    Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
    Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.